Key facts
- Primum Health’s last known valuation is $31.0M (Sep 2025).
- It has raised $11.1M; the latest was Seed Round ($3.6M) in Sep 2025.
- Notable investors include FCA Venture Partners, North Coast Ventures, Redesign Health.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Primum Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Primum Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Primum Health
Developer of a digital healthcare platform intended to connect physicians with the knowledge they need to treat complex patients. The company's platform offers an application that anonymizes physician perspectives into action, directly addressing identified gaps, and helps with complex cases, including myeloma, myeloid leukaemia, lymphoma and chronic lymphocytic leukaemia, enabling physicians to stay current on evolving treatments and clinical trials.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2021
- Employees
- 10
- Website
- primum.co/
- Ownership
- Privately Held (backing)
Primum Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Primum Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Primum Health in its N-PORT filings yet. We sweep new filings monthly.